Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
308 hedge funds and large institutions have $6.48B invested in Shockwave Medical, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 105 increasing their positions, 93 reducing their positions, and 55 closing their positions.
500% more funds holding in top 10
Funds holding in top 10: 1 → 6 (+5)
82% more call options, than puts
Call options by funds: $111M | Put options by funds: $61M
33% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 55
15% more capital invested
Capital invested by funds: $5.64B → $6.48B (+$841M)
13% more repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 93
5% more funds holding
Funds holding: 294 → 308 (+14)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$73.5M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$56.6M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$41.8M |
| 4 |
Jennison Associates
New York
|
+$35.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$31.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$80.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$57.2M |
| 3 |
FAM
Fred Alger Management
New York
|
-$54.5M |
| 4 |
Morgan Stanley
New York
|
-$39.2M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$36.8M |
SWAV Hedge Fund Activity: Q1 2022 in Review
308 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q1 2022, worth a combined $6.48B — up 15% from $5.64B a quarter earlier.
Buyers outnumbered sellers: 73 funds opened new SWAV positions and 55 closed out — a net gain of 18 holders — while 105 added to existing stakes and 93 trimmed.
The largest buyer was Millennium Management, adding an estimated $73.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $80.8M.
- 308 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q1 2022, up from 294 in Q4 2021.
- Funds reported $6.48B of Shockwave Medical, Inc. Common Stock stock for Q1 2022, up 15% quarter-over-quarter.
- 73 funds opened new Shockwave Medical, Inc. Common Stock positions in Q1 2022 and 55 closed out, a net change of +18 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q1 2022 was Millennium Management, an estimated $73.5M added.
- The largest Shockwave Medical, Inc. Common Stock seller in Q1 2022 was T. Rowe Price Associates, an estimated $80.8M sold.
Based on aggregated 13F filings for Q1 2022.